{"id":74497,"date":"2026-02-01T12:00:00","date_gmt":"2026-02-01T12:00:00","guid":{"rendered":"https:\/\/www.africa-press.net\/senegal\/politique\/analogues-du-glp-1-dans-le-traitement-de-lobesite"},"modified":"2026-02-01T21:50:24","modified_gmt":"2026-02-01T21:50:24","slug":"analogues-du-glp-1-dans-le-traitement-de-lobesite","status":"publish","type":"post","link":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite","title":{"rendered":"Analogues du GLP-1 dans le Traitement de L\u2019Ob\u00e9sit\u00e9"},"content":{"rendered":"<p><span style=\"color: #ff6600\"><strong>Africa-Press &#8211; Senegal. <\/strong><\/span>Attention aux carences, me\u0301susages et autres risques induits par les analogues du re\u0301cepteur du glucagon-like-peptide-1 (a-GLP-1), les nouveaux traitements du diabe\u0300te et de l\u2019obe\u0301site\u0301. Car si la conclusion de la dernie\u0300re enque\u0302te nationale de pharmacovigilance mene\u0301e de l\u2019e\u0301te\u0301 2023 a\u0300 l\u2019hiver 2025 par l\u2019Agence nationale de se\u0301curite\u0301 du me\u0301dicament et des produits de sante\u0301 (ANSM) confirme dans l\u2019ensemble le profil de se\u0301curite\u0301 de ces me\u0301dicaments, comme souvent, le diable se trouve dans les de\u0301tails.<\/p>\n<p><b>Troubles gastro-intestinaux: les effets secondaires les plus fre\u0301quents<\/b><\/p>\n<p>Le rapport concerne ici environ 870.000 patients utilisant les sept mole\u0301cules actuellement rembourse\u0301es en France: Trulicity (dulaglutide), Victoza (liraglutide), Xultophy (liraglutide) et Ozempic (se\u0301maglutide) dans le traitement du diabe\u0300te, Saxenda (liraglutide), Wegovy (se\u0301maglutide) a\u0300 partir de septembre 2024 et Mounjaro (tirze\u0301patide) a\u0300 partir de novembre 2024 dans le traitement de seconde intention de l\u2019obe\u0301site\u0301. Sans grande surprise, ce sont des troubles gastro-intestinaux (nause\u0301es, vomissements, constipation, diarrhe\u0301e) qui sont les plus souvent rapporte\u0301s (48%), tous cessant le plus souvent avec l\u2019arre\u0302t du traitement ou s\u2019estompant avec le temps. Mais ces effets secondaires be\u0301nins ne doivent pas en occulter d\u2019autres, eux plus rares mais bien plus se\u0301ve\u0300res.<\/p>\n<p>\u00ab Durant la pe\u0301riode e\u0301tudie\u0301e allant du 1er aou\u0302t 2023 au 31 janvier 2025, 376 cas graves ont e\u0301te\u0301 de\u0301clare\u0301s dont 140 concernaient l\u2019utilisation d\u2019aGLP-1 pour traiter l\u2019obe\u0301site\u0301. Dix-neuf de\u0301ce\u0300s ont e\u0301te\u0301 rapporte\u0301s chez des patients traite\u0301s par aGLP-1, sans qu\u2019un lien direct ait pu e\u0302tre e\u0301tabli avec ces me\u0301dicaments \u00bb, e\u0301crit l\u2019ANSM. La lecture du rapport re\u0301ve\u0300le aussi d\u2019autres signaux d\u2019effets inde\u0301sirables moins documente\u0301s, ne\u0301cessitant toutefois des mesures de pre\u0301vention ou une surveillance renforce\u0301e.<\/p>\n<p>Exemple avec un risque plus e\u0301leve\u0301 de cancer de la thyroi\u0308de. \u00ab Il s\u2019agit d\u2019un signal potentiel identifie\u0301 dans un pre\u0301ce\u0301dent rapport, e\u0301crit l\u2019ANSM. Deux nouvelles me\u0301ta-analyses d\u2019essais cliniques publie\u0301es en 2025 renforcent l\u2019hypothe\u0300se d\u2019un surrisque sous AR-GLP-1, non confirme\u0301 a\u0300 ce jour par le PRAC (le comite\u0301 de pharmacovigilance de l\u2019Agence europe\u0301enne des me\u0301dicaments, ndlr). Ces re\u0301sultats seront partage\u0301s au niveau europe\u0301en \u00bb.<\/p>\n<p><b>Des carences en fer et en vitamines<\/b><\/p>\n<p>Autre signal, lui nouvellement repe\u0301re\u0301: les carences en fer et en vitamines. \u00ab Les modifications quantitatives et qualitatives de l\u2019apport alimentaire associe\u0301es aux AR-GLP-1 peuvent exposer a\u0300 des carences graves. Ces risques ainsi que leurs complications ne\u0301cessitent une surveillance nutritionnelle et une supple\u0301mentation adapte\u0301e des patients \u00bb, pre\u0301cisent les autorite\u0301s sanitaires.<\/p>\n<p>Enfin, a\u0300 propos du risque de complications pouvant survenir lors d\u2019interventions ope\u0301ratoires chez ces patients, les rapporteurs proposent que \u00ab des recommandations claires pour leur gestion pe\u0301ri-ope\u0301ratoire soient e\u0301tablies en lien avec les socie\u0301te\u0301s savantes concerne\u0301es \u00bb.<\/p>\n<p>Et l\u2019Agence d\u2019enfin rappeler dans ses conclusions que d\u2019une part, les cas graves en lien avec le me\u0301susage sont toujours e\u0301vitables, en pre\u0301cisant que, sur les 36 cas d\u2019effet inde\u0301sirables rapporte\u0301s en lien avec cette pratique d\u2019ailleurs en augmentation, 25 e\u0301taient graves. Comme par exemple: \u00bb trois pancre\u0301atites aigue\u0308s survenues chez des patientes jeunes sans facteurs de risque identifiables, dont une pre\u0301sentant seulement un surpoids mode\u0301re\u0301 \u00bb.<\/p>\n<p>L\u2019Agence pre\u0301cise par ailleurs que les effets en lien avec un me\u0301susage sont survenus en l\u2019absence d\u2019escalade de dose (avec une dose forte prise d\u2019emble\u0301e) ou dans un contexte d\u2019usage non encadre\u0301 me\u0301dicalement. Parmi ces 36 cas, 22 concernent une situation ou\u0300 le me\u0301dicament a e\u0301te\u0301 obtenu en dehors d\u2019un circuit me\u0301dical officiel (via un proche, la famille, a\u0300 l\u2019e\u0301tranger), et 18 rapportent une dose initiale trop e\u0301leve\u0301e. La prudence est donc de mise.<\/p>\n<p><strong>Pour plus d&rsquo;informations et d&rsquo;analyses sur la <span style=\"color: #ff6600\">Senegal<\/span>, suivez <span style=\"color: #ff6600\">Africa-Press<\/span><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Africa-Press &#8211; Senegal. Attention aux carences, me\u0301susages et autres risques induits par les analogues du re\u0301cepteur du glucagon-like-peptide-1 (a-GLP-1), les nouveaux traitements du diabe\u0300te et de l\u2019obe\u0301site\u0301. Car si la conclusion de la dernie\u0300re enque\u0302te nationale de pharmacovigilance mene\u0301e de l\u2019e\u0301te\u0301 2023 a\u0300 l\u2019hiver 2025 par l\u2019Agence nationale de se\u0301curite\u0301 du me\u0301dicament et des produits [&hellip;]<\/p>\n","protected":false},"author":82,"featured_media":74496,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[22,10],"tags":[44],"class_list":["post-74497","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-divers","category-toutes-les-actualites","tag-senegal-2"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.1 (Yoast SEO v27.0) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Analogues du GLP-1 dans le Traitement de L\u2019Ob\u00e9sit\u00e9 - Senegal<\/title>\n<meta name=\"description\" content=\"Attention aux carences, me\u0301susages et autres risques induits par les analogues du re\u0301cepteur du glucagon-like-peptide-1 ...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Analogues du GLP-1 dans le Traitement de L\u2019Ob\u00e9sit\u00e9\" \/>\n<meta property=\"og:description\" content=\"Attention aux carences, me\u0301susages et autres risques induits par les analogues du re\u0301cepteur du glucagon-like-peptide-1 ...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite\" \/>\n<meta property=\"og:site_name\" content=\"Senegal\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-01T12:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-01T21:50:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2026\/02\/sm_1770000509.036331.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"cfeditorfr\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"cfeditorfr\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite\"},\"author\":{\"name\":\"cfeditorfr\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1\"},\"headline\":\"Analogues du GLP-1 dans le Traitement de L\u2019Ob\u00e9sit\u00e9\",\"datePublished\":\"2026-02-01T12:00:00+00:00\",\"dateModified\":\"2026-02-01T21:50:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite\"},\"wordCount\":696,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2026\/02\/sm_1770000509.036331.jpg\",\"keywords\":[\"Senegal\"],\"articleSection\":[\"Divers\",\"Toutes les actualit\u00e9s\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite\",\"url\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite\",\"name\":\"Analogues du GLP-1 dans le Traitement de L\u2019Ob\u00e9sit\u00e9 - Senegal\",\"isPartOf\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2026\/02\/sm_1770000509.036331.jpg\",\"datePublished\":\"2026-02-01T12:00:00+00:00\",\"dateModified\":\"2026-02-01T21:50:24+00:00\",\"author\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1\"},\"description\":\"Attention aux carences, me\u0301susages et autres risques induits par les analogues du re\u0301cepteur du glucagon-like-peptide-1 ...\",\"breadcrumb\":{\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite#primaryimage\",\"url\":\"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2026\/02\/sm_1770000509.036331.jpg\",\"contentUrl\":\"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2026\/02\/sm_1770000509.036331.jpg\",\"width\":1280,\"height\":720,\"caption\":\"Analogues du GLP-1 dans le Traitement de L\u2019Ob\u00e9sit\u00e9\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.africa-press.net\/senegal\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Analogues du GLP-1 dans le Traitement de L\u2019Ob\u00e9sit\u00e9\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/#website\",\"url\":\"https:\/\/www.africa-press.net\/senegal\/\",\"name\":\"Africa Press | Senegal | Homepage\",\"description\":\"Just another Africa News Agency Sites site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.africa-press.net\/senegal\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.africa-press.net\/senegal\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1\",\"name\":\"cfeditorfr\",\"url\":\"https:\/\/www.africa-press.net\/senegal\/author\/cfeditorfr\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Analogues du GLP-1 dans le Traitement de L\u2019Ob\u00e9sit\u00e9 - Senegal","description":"Attention aux carences, me\u0301susages et autres risques induits par les analogues du re\u0301cepteur du glucagon-like-peptide-1 ...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite","og_locale":"fr_FR","og_type":"article","og_title":"Analogues du GLP-1 dans le Traitement de L\u2019Ob\u00e9sit\u00e9","og_description":"Attention aux carences, me\u0301susages et autres risques induits par les analogues du re\u0301cepteur du glucagon-like-peptide-1 ...","og_url":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite","og_site_name":"Senegal","article_published_time":"2026-02-01T12:00:00+00:00","article_modified_time":"2026-02-01T21:50:24+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2026\/02\/sm_1770000509.036331.jpg","type":"image\/jpeg"}],"author":"cfeditorfr","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"cfeditorfr","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite#article","isPartOf":{"@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite"},"author":{"name":"cfeditorfr","@id":"https:\/\/www.africa-press.net\/senegal\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1"},"headline":"Analogues du GLP-1 dans le Traitement de L\u2019Ob\u00e9sit\u00e9","datePublished":"2026-02-01T12:00:00+00:00","dateModified":"2026-02-01T21:50:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite"},"wordCount":696,"commentCount":0,"image":{"@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite#primaryimage"},"thumbnailUrl":"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2026\/02\/sm_1770000509.036331.jpg","keywords":["Senegal"],"articleSection":["Divers","Toutes les actualit\u00e9s"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite","url":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite","name":"Analogues du GLP-1 dans le Traitement de L\u2019Ob\u00e9sit\u00e9 - Senegal","isPartOf":{"@id":"https:\/\/www.africa-press.net\/senegal\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite#primaryimage"},"image":{"@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite#primaryimage"},"thumbnailUrl":"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2026\/02\/sm_1770000509.036331.jpg","datePublished":"2026-02-01T12:00:00+00:00","dateModified":"2026-02-01T21:50:24+00:00","author":{"@id":"https:\/\/www.africa-press.net\/senegal\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1"},"description":"Attention aux carences, me\u0301susages et autres risques induits par les analogues du re\u0301cepteur du glucagon-like-peptide-1 ...","breadcrumb":{"@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite#primaryimage","url":"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2026\/02\/sm_1770000509.036331.jpg","contentUrl":"https:\/\/static.africa-press.net\/senegal\/sites\/13\/2026\/02\/sm_1770000509.036331.jpg","width":1280,"height":720,"caption":"Analogues du GLP-1 dans le Traitement de L\u2019Ob\u00e9sit\u00e9"},{"@type":"BreadcrumbList","@id":"https:\/\/www.africa-press.net\/senegal\/toutes-les-actualites\/analogues-du-glp-1-dans-le-traitement-de-lobesite#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.africa-press.net\/senegal\/"},{"@type":"ListItem","position":2,"name":"Analogues du GLP-1 dans le Traitement de L\u2019Ob\u00e9sit\u00e9"}]},{"@type":"WebSite","@id":"https:\/\/www.africa-press.net\/senegal\/#website","url":"https:\/\/www.africa-press.net\/senegal\/","name":"Africa Press | Senegal | Homepage","description":"Just another Africa News Agency Sites site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.africa-press.net\/senegal\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.africa-press.net\/senegal\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1","name":"cfeditorfr","url":"https:\/\/www.africa-press.net\/senegal\/author\/cfeditorfr"}]}},"_links":{"self":[{"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/posts\/74497","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/users\/82"}],"replies":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/comments?post=74497"}],"version-history":[{"count":0,"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/posts\/74497\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/media\/74496"}],"wp:attachment":[{"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/media?parent=74497"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/categories?post=74497"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.africa-press.net\/senegal\/wp-json\/wp\/v2\/tags?post=74497"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}